Genetics and Molecular Research · 2011 · 26 citations · 34 references
MedicineOncologyPathologyGastrointestinal OncologyMolecular OncologyNeoplasiaCancer Genomic InstabilityColonic DiseasesColorectal CancerGastrointestinal NeoplasmsMalignant NeoplasmsMicrosatellite InstabilityColorectal Cancer PathologyMicrosatellite Instability AnalysisMicrosatellite Instability BiomarkersMicrosatellite Instability In Colorectal CancerMicrosatellite Instability SubtypesMicrosatellite Instability TestingPolymerase Chain Reaction-based Microsatellite Instability AnalysisSporadic Colorectal Cancer
Microsatellite instability in sporadic colorectal cancer patients was assessed, and the clinicopathological associations were evaluated in northeastern Iran, which is a high-risk region for gastrointestinal malignancies. Microsatellite instability (MSI) status of tumoral tissue, compared to normal tissue, was assessed with a standard panel of MSI markers on paraffin-embedded surgically resected tissues from 67 consecutive sporadic colorectal cancer patients. Eleven of the patients were under 40 years old. Female patients were significantly younger than male patients (mean age 54.2 vs 62.1 years, P = 0.020). MSI analysis revealed 18 cases of MSI-H (26.9%), 11 MSI-L (16.4%) and 38 MSS (microsatellite stable tumors; 56.7%). While a greater proportion of patients consisted of males, 56.7 vs 43.3% females, MSI-H was more frequent in females (34.5 vs 21.5%). MSI was associated with proximal location of tumor (P = 0.003) and lower stages of tumor (P = 0.002), while MSS tumors were associated with node metastasis. MSI has a higher frequency in sporadic colorectal cancer patients, suggesting that molecular epidemiology of the genetic alterations involved in colorectal cancer carcinogenesis has a different pattern in the Iranian population, which deserves further epidemiological attention. The high frequency of MSI-H in this population suggests that we should look at microsatellite instability prior to chemotherapy to determine the most appropriate chemotherapeutic strategy in our population.
34
C. Richard Boland, Stephen N. Thibodeau, Stanley R. Hamilton et al. · PubMed · 1998 · 4.1K citations
Life Sciences, Genetics, Oncology +17
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
Jean‐Pierre J. Issa, Yvonne Ottaviano, P Celano et al. · Nature Genetics · 1994 · 1.2K citations
Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients
Bo Liu, Ramon Parsons, Nickolas Papadopoulos et al. · Nature Medicine · 1996 · 953 citations
Life Sciences, Genetics, Oncology +12